Cargando...

Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital

BACKGROUND: Living donor liver transplantation (LDLT) is an established treatment not only for those with end-stage liver disease but for those with hepatocellular carcinoma (HCC) developing in cirrhotic liver. The aim of this study was to present a single-center experience of LDLT for HCC at the Un...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Hepatobiliary Surg Nutr
Autores principales: Togashi, Junichi, Akamastu, Nobuhisa, Kokudo, Norihiro
Formato: Artigo
Lenguaje:Inglês
Publicado: AME Publishing Company 2016
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5075828/
https://ncbi.nlm.nih.gov/pubmed/27826554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2016.08.05
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!